Needham downgrades Cara Therapeutics to Hold on lack of pipeline
PremiumThe FlyNeedham downgrades Cara Therapeutics to Hold on lack of pipeline
3M ago
Cara Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Cara Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
3M ago
Cara Therapeutics downgraded to Hold from Buy at Needham
Premium
The Fly
Cara Therapeutics downgraded to Hold from Buy at Needham
3M ago
Cara Therapeutics trading resumes
PremiumThe FlyCara Therapeutics trading resumes
3M ago
Cara to wind down clinical program in NP and explore strategic alternatives
Premium
The Fly
Cara to wind down clinical program in NP and explore strategic alternatives
3M ago
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
Premium
Press Releases
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
3M ago
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
PremiumPress ReleasesCara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
5M ago
CARA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CARA Earnings this Week: How Will it Perform?
5M ago
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Premium
Press Releases
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100